Drug Development Policy

At the Mercy of a Few: Patents, Market Concentration and Global Access to Medicines

Posted on

Market concentration in high-technology industries has become a subject of interest to scholars and policy analysts. This talk presents some of the first empirical results on how the patenting system contributes to market concentration in the pharma and chemical sectors globally. Please RSVP  Thursday February 21, 2019 at noon Harvard Law School Wasserstein Hall Room […]

Events

Upcoming Panel: Substandard and Counterfeit Medicines in Africa: A Human Rights Perspective

Posted on

Marking 70 years of the Universal Declaration of Human Rights.  Join Global Access in Action on the International Human Rights Day Celebration to discuss how to improve access to medicines in Africa. Panelists: Ashveena Gajeelee (GAiA); Bright Simons (Founder mPedigree); Rick Wolthusen (Co-founder On the Move e.V; and Helen Tesfaye (HSPH). Date: December 10, 2018 […]

Digital Health @ Harvard

Digital Health @ Harvard, November 27 : Computer Simulations to Enhance Vaccine Trials

Posted on

November 27, 2018 12:00 PM Wasserstein Hall, Milstein East C (2036) Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Video and Podcast of the event (courtesy of Berkman Klein Center). Infectious disease emergencies are opportunities to test the efficacy of newly developed interventions—for example, drugs, vaccines, and treatment regimens. Yet they raise many intertwined challenges […]

Events

Speaker Series October 17: Achieving Equitable Access to Vaccines: From Policies to Provisions

Posted on

Join Us to discuss ways of achieving equitable access to vaccines on 17 October 2018, 11:00 at WCC 3013, Harvard Law School. Register now! In order to achieve the objectives of global health organizations, policies must be translated into actionable provisions and agreements. The Global Healthcare Innovation Alliance Accelerator endeavors to provide tools and guidance to organizations […]